Fredun Pharmaceuticals Raises Revenue 84.19% and Net Profit 96.92% in Second Quarter
Key Facts
Fredun Pharmaceuticals recorded revenue of 267.63 crore rupees in the second quarter of fiscal 2027, up 84.19% year on year and 17.25% from the previous quarter, according to Business Standard data. Net profit was 18.57 crore rupees, up 96.92% from the same period a year earlier and 41.43% quarter on quarter. Operating profit reached 42.35 crore rupees, up 89.57% year on year and 29.35% quarter on quarter. The results cover the quarter ended September 30, 2026, within fiscal 2026-2027. Net profit grew faster than revenue during the period, while operating and profitability metrics also rose compared with the previous quarter.
On a quarterly basis, revenue rose from 228.25 crore rupees in the first quarter of fiscal 2027 to 267.63 crore in the second quarter, while operating profit climbed from 32.74 crore to 42.35 crore. Net profit increased from 13.13 crore rupees to 18.57 crore. Revenue growth in the first quarter was 90.45% year on year, before reaching 84.19% in the second quarter. Net profit also recorded year-on-year growth of 93.94% in the first quarter, compared with an increase of 96.92% in the second quarter. These comparisons place the latest quarter's results alongside the performance recorded at the start of the fiscal year.
As part of its expansion in pet care, Fredun acquired a 26% stake in Goodman Vetcare in September 2026. Business Standard reported that Goodman revenue rose from 14.1 crore rupees in fiscal 2024 to 23.6 crore in fiscal 2026, an annual growth rate of 30%. Managing Director Fredun Madhura said the company sees "a significant opportunity to build on this foundation by combining Goodman Vetcare's market strength with FPL's brands, manufacturing capabilities and broader ecosystem." This strategy presents an opportunity to expand the company's presence in pet health products and services alongside its existing businesses. The company's comments link this path to integrating Goodman's network with Fredun's brands and manufacturing.
The company announced in September that it had acquired the Furlicks pet care brand. On September 8, 2026, Fredun shares fell 6.02% to 1,322 rupees, according to a Business Standard report on trading following the acquisition announcement. In a later development, the shares closed at 1,501.25 rupees on November 13, 2026, down 2.01% during the session, according to Business Standard's price page. These levels relate to two dates separate from the quarterly results announcement and do not describe the stock's movement in the session when the results were published. These developments add a timeline around share movements linked to the company's announcements and expansion in pet care.